Nanobac Pharmaceuticals Incorporated (NNBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2005 | 03-2005 | 12-2004 | 09-2004 | 06-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,170 | -780 | -7,870 | -6,650 | -5,660 |
| Depreciation Amortization | 370 | 180 | 710 | 580 | 360 |
| Other Working Capital | -370 | -30 | 960 | 690 | 760 |
| Other Operating Activity | 770 | 10 | 2,810 | 2,810 | 2,740 |
| Operating Cash Flow | $-1,400 | $-620 | $-3,390 | $-2,570 | $-1,800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | -30 | -30 | -20 | -20 |
| Net Acquisitions | 0 | 0 | -1 | -1 | -1 |
| Other Investing Activity | 0 | 0 | 191 | 191 | 191 |
| Investing Cash Flow | $-30 | $-30 | $160 | $170 | $170 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,410 | 630 | 3,210 | 2,360 | 1,600 |
| Financing Cash Flow | $1,410 | $630 | $3,210 | $2,360 | $1,600 |
| Exchange Rate Effect | 30 | 10 | -10 | -4 | 5 |
| Beginning Cash Position | 10 | 10 | 40 | 40 | 50 |
| End Cash Position | 20 | 10 | 10 | 10 | 20 |
| Net Cash Flow | $4 | $-5 | $-30 | $-30 | $-20 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,400 | -620 | -3,390 | -2,570 | -1,800 |
| Free Cash Flow | -1,400 | -620 | -3,390 | -2,570 | -1,800 |